Vyant Bio, Inc. filed its 10-K on Mar 31, 2023 for the period ending Dec 31, 2022. In this report its auditor, Deloitte & Touche LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
1st Jan change | Capi. | |
---|---|---|
+199.94% | 7.44B | |
+8.21% | 1.09B | |
+2.00% | 981M | |
+41.91% | 872M | |
+23.88% | 797M | |
+1.72% | 664M | |
+11.31% | 648M | |
-.--% | 600M | |
+3.61% | 503M |